Ovarian adenocarcinoma
Clinical trials for Ovarian adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Ovarian adenocarcinoma trials appear
Sign up with your email to follow new studies for Ovarian adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New biologic drug DBC-664 takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing an experimental biologic drug, DBC-664, in adults with advanced solid tumors such as ovarian, lung, and stomach cancers that have spread or come back. The study has two parts: first, finding a safe dose, and then expanding to see how well the dru…
Matched conditions: OVARIAN ADENOCARCINOMA
Phase 1 • Sponsor: Duboce Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Smartwatch workouts aim to beat Post-Chemo fatigue
Symptom relief Recruiting nowThis study tests whether a personalized exercise program, tracked by a smartwatch, can help reduce fatigue in people who have finished chemotherapy for certain cancers (breast, colorectal, ovarian, pancreatic, or gastric). About 98 participants will be randomly assigned to either…
Matched conditions: OVARIAN ADENOCARCINOMA
Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a simple blood test predict leukemia risk after cancer therapy?
Knowledge-focused Recruiting nowThis study investigates clonal hematopoiesis (CH) — small mutations in blood cells that can arise naturally or after cancer treatment — in adults receiving chemotherapy or radiation for solid tumors like breast, lung, or colorectal cancer. Researchers will collect blood, saliva, …
Matched conditions: OVARIAN ADENOCARCINOMA
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC